Citation: At. Masi et Jc. Aldag, Do antifilaggrin antibodies within the "normal" range predict rheumatoid arthritis?, J RHEUMATOL, 28(7), 2001, pp. 1736-1737
Citation: At. Masi et al., Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: Correlations with pre-RA status and baseline positive rheumatoid factors, J RHEUMATOL, 28(10), 2001, pp. 2359-2360
Citation: At. Masi, Hormonal and immunologic risk factors for the development of rheumatoid arthritis: An integrative physiopathogenetic perspective, RHEUM DIS C, 26(4), 2000, pp. 775
Citation: At. Masi et al., Adrenal androgen and glucocorticoid dissociation in premenopausal rheumatoid arthritis: a significant correlate or precursor to onset?, Z RHEUMATOL, 59, 2000, pp. 54-61
Citation: At. Masi et Rt. Chatterton, Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients, SC J RHEUM, 29(2), 2000, pp. 85-88
Citation: At. Masi et al., Enigmas of adrenal androgen and glucocorticoid dissociation in premenopausal onset rheumatoid arthritis, J RHEUMATOL, 26(2), 1999, pp. 247-250
Citation: At. Masi et Jc. Aldag, Significantly increased frequency of baseline IgA anti-type II collagen positivity in the placebo group in a study of oral type II collagen treatmentof rheumatoid arthritis: comment, ARTH RHEUM, 42(3), 1999, pp. 585-587
Citation: At. Masi, Concepts of illness in populations as applied to fibromyalgia syndromes: abiopsychosocial perspective, Z RHEUMATOL, 57, 1998, pp. 31-35